Source link : https://newshealth.biz/health-news/fda-approves-drug-for-aggressive-glioma/
The FDA has granted accelerated approval to dordaviprone (Modeyso, Jazz Pharmaceuticals) for H3 K27M-mutant diffuse glioma, marking the first time a systemic therapy has been approved for the aggressive glioma subtype. H3 K27M-mutant diffuse glioma is a grade 4 midline tumor that primarily affects children and young adults. Median survival is about a year. Historically, […]
The post FDA Approves Drug for Aggressive Glioma first appeared on News Health.
—-
Author : News Health
Publish date : 2025-08-06 21:30:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8